Related Experiment Video
Updated: Nov 26, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Immune thrombocytopenia associated with tuberculosis - A case report
Adeel Ahmad Khan1, Aamir Shahzad1, Haleema Javid2
1Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Tuberculosis can affect blood cell counts, including a rare condition called immune thrombocytopenia. This case shows a patient whose low platelet count was successfully treated with steroids and tuberculosis medications.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Background:
- Tuberculosis (TB) can manifest with various hematological abnormalities, including anemia and altered white blood cell counts.
- Immune thrombocytopenia, a condition characterized by low platelet counts due to an autoimmune response, is an uncommon complication of tuberculosis.
- Disseminated tuberculosis, affecting multiple organ systems, presents diagnostic challenges.
Observation:
- A 54-year-old male presented with isolated asymptomatic thrombocytopenia detected during routine blood work.
- Diagnostic workup revealed findings consistent with disseminated tuberculosis.
- The patient had no other apparent symptoms or signs of active infection initially.
Findings:
- The patient's thrombocytopenia significantly improved and remained stable following treatment.
- Treatment involved a tapering course of corticosteroids and standard anti-tuberculous medications.
- Platelet count recovery was observed concurrently with the management of disseminated tuberculosis.
Implications:
- This case highlights the importance of considering tuberculosis in the differential diagnosis of unexplained thrombocytopenia, even in asymptomatic individuals.
- Early diagnosis and appropriate treatment of disseminated tuberculosis are crucial for resolving associated hematological complications like immune thrombocytopenia.
- The successful management with steroids and anti-TB therapy suggests a potential immune-mediated mechanism linking tuberculosis and thrombocytopenia.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...